The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cancer Care Beyond Walls (CCBW): A randomized pragmatic trial of home-based versus in-clinic cancer therapy administration.
 
Roxana Dronca
Honoraria - BMS; BMS; BMS (Inst); Eisai; Elsevier; EMD Serono; Natera; Replimune
Consulting or Advisory Role - BMS; BMS; BMS (Inst); Eisai; Elsevier; EMD Serono; Genzyme; Natera; Replimune
Research Funding - Alkermes (Inst); BMSi (Inst); BMSi (Inst); Emerson Collective (Inst); Merck Sharp & Dohme (Inst); Phosplatin Therapeutics (Inst); Regeneron (Inst); Regeneron (Inst); Sorrento Therapeutics (Inst); Spirita (Inst)
Patents, Royalties, Other Intellectual Property - Development of a Novel CAR-T Therapy to Tackle the Challenges of Immune Evasion
Travel, Accommodations, Expenses - BMSi; Replimune
Other Relationship - Elsevier
 
Jeremy Jones
No Relationships to Disclose
 
Hemant Murthy
Consulting or Advisory Role - Acceleron Pharma; Autolus; Bavarian Nordic; Bristol Myers Squibb Foundation; CRISPR Therapeutics; Jazz Pharmaceuticals; Senti Biosciences; SOBI
Research Funding - Abbvie (Inst); Amgen (Inst); crispr therapeutics (Inst)
 
Pooja Advani
Stock and Other Ownership Interests - Abbvie (I); Alpha2 Pharmaceuticals (I); NanoString Technologies (I); Sorrento Therapeutics (I)
Honoraria - Ascentage Pharma Group (I); AstraZeneca (I); AstraZeneca (Inst); Epic Sciences; Epic Sciences; GE Healthcare; Menarini Group; OncLive/MJH Life Sciences
Consulting or Advisory Role - Ascentage Pharma (I); AstraZeneca (I); AstraZeneca (Inst); BMS (I); Breathe BioMedical; Puma Biotechnology
Speakers' Bureau - AstraZeneca (Inst); GE hea; Menarini
Research Funding - Ascentage Pharma (I); AstraZeneca (Inst); Atossa Therapeutics (Inst); Ayala Pharmaceuticals (Inst); biovica (Inst); Bristol Myer Squibb (I); Caris Life Sciences (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Loxo/Lilly (Inst); Seagan (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - patent pending on PCT-US2020-067237 (cancer vaccine platform) (I)
Travel, Accommodations, Expenses - Caris Life Sciences; Tempus (I)
 
Ricardo Parrondo
Consulting or Advisory Role - AstraZeneca; Sanofi Aventis GmbH
Research Funding - Bristol Myers Squibb Foundation; GlaxoSmithKline
Expert Testimony - MJH Life Sciences
 
Sikander Ailawadhi
Consulting or Advisory Role - Amgen (Inst); Beigene; BMS (Inst); Cellectar (Inst); GlaxoSmithKline; Janssen (Inst); Pharmacyclics (Inst); Regeneron; Sanofi; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Ascentage Pharma (Inst); BMS (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Biotech (Inst); Pharmacyclics (Inst); Sanofi (Inst)
 
Gina Mazza
Research Funding - Bristol Myers Squibb Foundation (Inst); Pfizer (Inst)
 
Sunnie Confiado
Employment - Mayo Clinic
 
Amber Baskin
Employment - Mayo Clinic
 
Grzegorz Nowakowski
Consulting or Advisory Role - Abbvie; Bantam Pharmaceutical; Bristol-Myers Squibb/Celgene; Celgene (Inst); Debiopharm Group; Genentech (Inst); Genmab; Karyopharm Therapeutics; Kite/Gilead; kymera; MorphoSys (Inst); Roche Pharma AG (Inst); Ryvu Therapeutics; Selvita; TG Therapeutics
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)
 
Tufia Haddad
Research Funding - Puma Biotechnology (Inst); Takeda (Inst)
 
Winston Tan
Honoraria - Medscape; Onclive
 
Adam Kase
No Relationships to Disclose
 
Cheryl Willman
Patents, Royalties, Other Intellectual Property - Patents related to genomic diagnostics for cancer